Skip to main content
letter
. 2020 Sep 27;34(11):e14070. doi: 10.1111/ctr.14070

Figure 1.

Figure 1

Results from GEP (AlloMap™) and dd‐cfDNA (AlloSure™) testing in a patient with COVID‐19. The dotted line represents symptom onset. The dd‐cfDNA level doubled during the acute phase of the infection but returned to baseline levels 24 d later